Viatris, Astellas to Wind Up Lipitor Copromotion at July-End

Viatris Pharmaceuticals Japan and Astellas Pharma said on April 1 that they will terminate the copromotion of the hypercholesterolemia treatment Lipitor (atorvastatin) in Japan at the end of July. Beginning on August 1, Viatris will be solely responsible for the...read more